Lv3
340 积分 2026-01-30 加入
The African Medicines Agency: historical perspective of its origins, evolution, institutional structure and future prospects
18天前
已完结
Patent Portfolios Protecting 10 Top-Selling Prescription Drugs
30天前
已完结
The public health impact of the Medicines Patent Pool increases with the fragmentation of intellectual property rights
1个月前
已完结
Trends in the landscape of clinical trials of innovative drugs in China since 2015
2个月前
已完结
Regulation of Real‐World Evidence in Rare Diseases in the MENA Region: A Review of Current Guidelines Compared to Global Frameworks
3个月前
已完结
Post‐Approval Pediatric Use of Drugs Granted Waivers from Pediatric Testing
3个月前
已完结
Delisting of Pharmaceutical Patents Challenged by the Federal Trade Commission
3个月前
已完结
Navigating Regulatory Pathways for Access to Innovative Medicines in Tunisia
3个月前
已完结
Skinny Labels at the Supreme Court—Generic Competition, Patent Inducement, and Affordable Medicines
3个月前
已关闭
Limited Progression of Nuclear Sclerosis after Lens-Sparing Vitrectomy in Proliferative Diabetic Retinopathy Eyes: A Real-World Investigation with Scheimpflug Lens Densitometry
4个月前
已关闭
皖公网安备34019202002308
